The global beauty company, Avon Products Inc. (NYSE:AVP) reported adjusted earnings of 12 cents per share for first-quarter 2014, below the Zacks Consensus Estimate of 20 cents and plunged 50% from the year-ago quarter’s earnings of 26 cents. Products, Inc. (NYSE:AVP) shares after opening at $14.10 moved to $14.13 on last trade day and at the end of the day closed at $13.72. Company price to sales ratio in past twelve months was calculated as 0.60 and price to cash ratio as 5.23. Avon Products, Inc. (NYSE:AVP) showed a negative weekly performance of -8.23%.
Pepco Holdings Inc. (NYSE:POM) the company once named the “most hated company in America” in a 2011 survey by Business Insider is being sold for $6.9 billion in cash to Chicago-based utility operator Exelon. Pepco Holdings, Inc. (NYSE:POM) shares advanced 0.64% in last trading session and ended the day on $26.93. POM return on equity ratio is recorded as -15.00% and its return on assets is -4.30%. Pepco Holdings, Inc. (NYSE:POM) yearly performance is 26.79%.
ProShares Ultra 7-10 Year Treasury ETF (NYSEARCA:UST) a premier provider of alternative exchange traded funds, announced the launch of the ProShares DJ Brookfield Global Infrastructure ETF (TOLZ), the first ETF providing “pure-play” exposure to infrastructure. ProShares Ultra 7-10 Year Treasury ETF (NYSEARCA:UST) shares moved up 0.55% in last trading session and was closed at $52.67, while trading in range of $52.37 – $52.84. ProShares Ultra 7-10 Year Treasury ETF (NYSEARCA:UST) year to date (YTD) performance is 7.71%.
Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) announced that company management will present an overview of the company at the following conferences in May. Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) weekly performance is 33.24%. On last trading day company shares ended up $4.65. Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) distance from 50-day simple moving average (SMA50) is 21.14%. Analysts mean target price for the company is $7.57.